Ripple Rules Out IPO Plans Despite $40 Billion Valuation and Industry Public Listing Wave
Ripple has no plans to go public, choosing to expand privately through strategic acquisitions and investor partnerships—setting itself apart as other major crypto firms rush toward IPOs.
Ripple, the blockchain company behind the XRP token, has no intention of pursuing an initial public offering, according to its president.
The announcement stands in contrast to a surge of cryptocurrency firms racing toward public markets this year.
Ripple Opts Out of IPO Rush
At the Swell conference in New York, Ripple’s president, Monica Long, reiterated the company’s decision not to pursue an initial public offering.
“We do not have an IPO timeline. No plan, no timeline,” Long told Bloomberg.
She explained that Ripple is in a “fortunate” position, allowing it to fund both organic and inorganic growth, as well as strategic partnerships, without turning to public markets.
“We are not focused on an IPO right now. We have the balance sheet, the liquidity to be growing and making moves on M&A and other big strategic partnerships,” Long mentioned to CNBC.
Ripple has invested around $4 billion in strategic acquisitions and mergers. Over the past two years, the company has completed six major deals.
The largest was the $1.25 billion acquisition of Hidden Road, now rebranded as Ripple Prime. Other significant transactions include the $1 billion purchase of GTreasury, a $200 million acquisition of Rail, and the recent takeover of Palisade, a digital asset custody platform.
Meanwhile, Ripple’s decision to remain private comes amid a $500 million funding round led by Fortress Investment Group, Citadel Securities, and Pantera Capital. The investment values Ripple at $40 billion.
Nonetheless, the president emphasized that Ripple did not need to raise additional capital. The deal was driven by strong interest from institutional investors who wanted to acquire a stake in the company.
It is worth noting that Ripple has not always dismissed the idea of going public. The company previously sparked IPO buzz in 2023. However, legal challenges prompted it to put this on hold in 2024.
CEO Brad Garlinghouse even considered the possibility of listing outside the US at the time, but shelved these plans. Now, the company’s latest position suggests that public listing options are completely off the table.
From Circle to Kraken: Crypto IPO Wave Gains Steam
While an IPO is not currently on Ripple’s agenda, President Long expressed support for other firms taking this route.
“We are really pleased to see crypto companies going public, that is great for our overall industry continuing to mature,” Long said.
Growing institutional interest and a more favorable regulatory environment have driven a surge in IPO plans among crypto companies this year. For instance, stablecoin issuer Circle completed its IPO earlier this year, followed by Bullish, Gemini, and blockchain lender Figure Technology.
Custody provider BitGo has filed with the SEC, while Grayscale Investments has also submitted a draft registration for its shares. OKX and CoinShares are also exploring similar plans. Crypto exchange Kraken is targeting a 2026 public launch after recently raising $500 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Voices of doubt arise, Moderna CEO reassures the market: Personalized cancer vaccines will cover more types of cancer
Moderna's CEO is highly confident about the prospects of the personalized mRNA cancer vaccine intismeran autogene, stating that it will play a role in more cancers beyond melanoma and drawing parallels with Merck's blockbuster drug Keytruda. Jefferies warns that cross-indication replication is still inconclusive; Citi maintains a "sell" rating, pointing out that commercial application remains limited, with critical issues such as patient suitability, manufacturing, and overall survival data yet to be addressed.

Morgan Stanley Declares U.S. Stock Market Correction Nears End! Maintains Year-End S&P 8000 Target, Identifies Three Major Rebound Catalysts
As Morgan Stanley remains bullish on the stock market, recent market trends have precisely demonstrated the strong rebound momentum of tech stocks dominated by the semiconductor sector. The Philadelphia Semiconductor Index rose by 0.44% on October 23rd and further increased by 2.82% on the 26th.

Eight Highlights of Anthropic IPO Prospectus: Astonishing Growth, but Risks are Obvious
The Anthropic prospectus reveals several highlights: a large-scale enterprise customer base with over 1,900 customers generating more than one million dollars in revenue; as of June 2026, revenue has increased by 1,368% year over year, far surpassing the growth rate of computing costs; positive operating cash flow; and all seven co-founders remain with the company. The company also acknowledges risks, including concentrated supply from TSMC and potential memory chip shortages as significant concerns. October ARR data will be additionally disclosed in a revised version of the document.

Selling Chips, Leasing, Providing Residual Value Support: Broadcom (AVGO.US) Teams Up with Wall Street's Four Giants to Raise $63 Billion to "Inject Funds" for Anthropic's Chip Procurement
Broadcom has reached a $63 billion deal with Bank of America, Blackstone Group, Citigroup, and Morgan Stanley to provide funding for the purchase of chips for AI model developer Anthropic PBC. The transaction is conducted through a newly established special purpose company, which has secured financial commitments from these firms to purchase Broadcom chips and lease them to Anthropic.

